These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22963924)

  • 21. Postsynaptic and presynaptic group II metabotropic glutamate receptor activation reduces neuronal excitability in rat midline paraventricular thalamic nucleus.
    Hermes ML; Renaud LP
    J Pharmacol Exp Ther; 2011 Mar; 336(3):840-9. PubMed ID: 21139059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GluK1 inhibits calcium dependent and independent transmitter release at associational/commissural synapses in area CA3 of the hippocampus.
    Salmen B; Beed PS; Ozdogan T; Maier N; Johenning FW; Winterer J; Breustedt J; Schmitz D
    Hippocampus; 2012 Jan; 22(1):57-68. PubMed ID: 20848601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate.
    Hassel B; Iversen EG; Gjerstad L; Taubøll E
    J Neurochem; 2001 Jun; 77(5):1285-92. PubMed ID: 11389179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of valproate.
    Owens MJ; Nemeroff CB
    Psychopharmacol Bull; 2003; 37 Suppl 2():17-24. PubMed ID: 14624230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate doubles the anoxic survival time of normal developing mice: possible relevance to valproate-induced decreases in cerebral levels of glutamate and aspartate, and increases in taurine.
    Thurston JH; Hauhart RE
    Life Sci; 1989; 45(1):59-62. PubMed ID: 2501608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GABA-ergic component in the mechanism of action of the psychostimulant sidnocarb].
    Ganiev MM; Kharlamov AN; Shumkova OV
    Farmakol Toksikol; 1984; 47(3):30-5. PubMed ID: 6329817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.
    Sitges M; Chiu LM; Nekrassov V
    Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of antiepileptic and antimyoclonic drugs.
    Pranzatelli MR; Nadi NS
    Adv Neurol; 1995; 67():329-60. PubMed ID: 8848979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of valproate on glutamate metabolism in rat brain slices: a (13)C NMR study.
    El Hage M; Baverel G; Martin G
    Epilepsy Res; 2012 Mar; 99(1-2):94-100. PubMed ID: 22088480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate decreases frequency facilitation at mossy fiber--CA3 synapses after status epilepticus.
    Chang P; Walker MC
    Epilepsy Res; 2011 Feb; 93(2-3):192-6. PubMed ID: 21167688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate reduced synaptic activity increase induced by 4-aminopyridine at the hippocampal CA3-CA1 synapse.
    Martín ED; Pozo MA
    Epilepsia; 2004 May; 45(5):436-40. PubMed ID: 15101824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presynaptic effects of grayanotoxin III on excitatory and inhibitory nerve terminals in rat ventromedial hypothalamic neurons.
    Kim SE; Shin MC; Akaike N; Kim CJ
    Neurotoxicology; 2010 Mar; 31(2):230-8. PubMed ID: 20038438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.
    Löscher W
    Neurochem Res; 1993 Apr; 18(4):485-502. PubMed ID: 8097295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice.
    Chapman AG; Croucher MJ; Meldrum BS
    Biochem Pharmacol; 1984 May; 33(9):1459-63. PubMed ID: 6428419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of anticonvulsant action of valproate.
    Chapman A; Keane PE; Meldrum BS; Simiand J; Vernieres JC
    Prog Neurobiol; 1982; 19(4):315-59. PubMed ID: 6134304
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of pharmacological manipulation on neurotransmitter and other amino acid levels in the CSF of the Senegalese baboon Papio papio.
    Valin A; Voltz C; Naquet R; Lloyd KG
    Brain Res; 1991 Jan; 538(1):15-23. PubMed ID: 1673360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory amino acid transmitters in epilepsy.
    Meldrum BS
    Epilepsia; 1991; 32 Suppl 2():S1-3. PubMed ID: 1723042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic valproic acid therapy and synaptic markers of amino acid neurotransmission.
    Slevin JT; Ferrara LP
    Neurology; 1985 May; 35(5):728-31. PubMed ID: 3921873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of neurotransmission of valproate sodium in suppressing barbiturate and phenytoin withdrawal syndrome.
    Peichev L
    Folia Med (Plovdiv); 1992; 34(2):14-9. PubMed ID: 1364082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproate and neuroprotection.
    Vajda FJ
    J Clin Neurosci; 2002 Sep; 9(5):508-14. PubMed ID: 12383405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.